Bi Lianxiang, Wacker Bradley K, Dichek David A
Department of Medicine, University of Washington School of Medicine.
Department of Medicine, University of Washington School of Medicine;
J Vis Exp. 2018 Sep 10(139):57231. doi: 10.3791/57231.
Vein graft bypass surgery is a common treatment for occlusive arterial disease; however, long-term success is limited by graft failure due to thrombosis, intimal hyperplasia, and atherosclerosis. The goal of this article is to demonstrate a method for placing bilateral venous interposition grafts in a rabbit, then transducing the grafts with a gene transfer vector that achieves durable transgene expression. The method allows the investigation of the biological roles of genes and their protein products in normal vein graft homeostasis. It also allows the testing of transgenes for the activities that could prevent vein graft failure, e.g., whether the expression of a transgene prevents the neointimal growth, reduces the vascular inflammation, or reduces atherosclerosis in rabbits fed with a high-fat diet. During an initial survival surgery, the segments of right and left external jugular vein are excised and placed bilaterally as reversed end-to-side common carotid artery interposition grafts. During a second survival surgery, performed 28 days later, each of the grafts is isolated from the circulation with vascular clips and the lumens are filled (via an arteriotomy) with a solution containing a helper-dependent adenoviral (HDAd) vector. After a 20-min incubation, the vector solution is aspirated, the arteriotomy is repaired, and flow is restored. The veins are harvested at time points dictated by individual experimental protocols. The 28-day delay between the graft placement and the transduction is necessary to ensure the adaptation of the vein graft to the arterial circulation. This adaptation avoids rapid loss of transgene expression that occurs in vein grafts transduced before or immediately after grafting. The method is unique in its ability to achieve durable, stable transgene expression in grafted veins. Compared to other large animal vein graft models, rabbits have advantages of low cost and easy handling. Compared to rodent vein graft models, rabbits have larger and easier-to-manipulate blood vessels that provide abundant tissue for analysis.
静脉移植搭桥手术是治疗闭塞性动脉疾病的常用方法;然而,由于血栓形成、内膜增生和动脉粥样硬化导致的移植失败限制了其长期成功率。本文的目的是展示一种在兔子体内植入双侧静脉间置移植物的方法,然后用一种能实现持久转基因表达的基因转移载体转导这些移植物。该方法可用于研究基因及其蛋白质产物在正常静脉移植物内环境稳定中的生物学作用。它还可以测试转基因是否具有预防静脉移植物失败的活性,例如,转基因的表达是否能阻止新生内膜生长、减轻血管炎症或减少高脂饮食喂养的兔子的动脉粥样硬化。在初次存活手术中,切除左右颈外静脉段,并将其双侧作为反向端侧颈总动脉间置移植物植入。在28天后进行的第二次存活手术中,用血管夹将每个移植物与循环系统隔离,通过动脉切开术将含有辅助依赖腺病毒(HDAd)载体的溶液注入管腔。孵育20分钟后,吸出载体溶液,修复动脉切开处,并恢复血流。根据个体实验方案确定的时间点采集静脉。移植物植入和转导之间延迟28天是必要的,以确保静脉移植物适应动脉循环。这种适应可避免在移植前或移植后立即转导的静脉移植物中发生的转基因表达快速丧失。该方法的独特之处在于能够在移植静脉中实现持久、稳定的转基因表达。与其他大型动物静脉移植物模型相比,兔子具有成本低和易于操作的优点。与啮齿动物静脉移植物模型相比,兔子的血管更大且易于操作,可为分析提供丰富的组织。